Analysis of human papillomavirus type 16 E5 oncogene expression in vitro and from bicistronic messenger RNAs

Intervirology

Volumn 38, Issue 6, 1995, Pages 339-345

  Johnsen, Christina Koefoed ^a   Stanley, Margaret ^b   Norrild, Bodil ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

E5 oncogene expression; Papillomavirus, human

Indexed keywords

MESSENGER RNA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CISTRON; CODON; MOUSE; NONHUMAN; OPEN READING FRAME; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SPLICING; VIRUS ONCOGENE; WART VIRUS;

3T3 CELLS; ANIMALS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENES; MICE; ONCOGENE PROTEINS, VIRAL; ONCOGENES; OPEN READING FRAMES; PAPILLOMAVIRIDAE; RNA, MESSENGER;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0029548484     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150461     Document Type: Article

References (39)

1. De Villiers EM: Heterogeneity of the human papillomavirus group. J Virol 1989;63:4898-4903.
2. Schneider A, Koutsky LA: Natural history and epidemiological features of genital HPV infection; in Munoz N, Bosch FX. Shah KV, Me-hcus A (eds): The Epidemiology of Human Papillomaviruses and Cervical Cancer. IARC Sci Publ 1992;119:25-52.
3. Van den Brule AJC. Waldboomers JMM. du Maine M. Kenemans P. Meijer CJLM: Difference in prevalence of human papillomavirus genotypes in cytomorphologically cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991:48: 404-408.
4. Hubbert NL. Sedman SA. Schiller JT: Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J Virol 1992;66:6237-6241.
5. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science 1990:248:76-79.
6. Schmitt A. Harry JB. Rapp B. Wettstein FO. Iftner T: Comparison of the properties of the E6 and E7 genes of low-and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb binding activity for the E7 protein of the low-risk human papillomavirus type 1. J Virol 1994;68:7051-7059.
7. Dyson N. Howley PM, Munger K, Harlow E: The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 1989:243:934-937.
8. Leptak C, Cajal SR, Kulke R, Horowitz BH, Riese DJ, Dotto GP. Dimaio D: Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. J Virol 1991; 65:7078-7083.
9. Leechanachai PL. Banks L. Moreau F, Matla-shewski G: The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 1992;7:19-25.
10. Goldstein DJ, Finbow ME, Andresson T, Mclean P. Smith K. Bubb V. Schlcgel R: The bovine papillomavirus E5 oncoprotein binds to the 16 kilodalton component of vacuolar H+-ATPases. Nature 1992;352:347-349.
11. Conrad M, Bubb V, Schlcgel R: The human papillomavirus type 6 and 16 E5 proteins arc membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol 1993;67:6170-6178.
12. Straight SW. Herman B, McCancc DJ: The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 1995;69:3185-3192.
13. Prakash SS, Horowitz BH. Zibello T, Settle-man J. DiMaio D: Bovine papillomavirus E2 gene regulates expression of the viral E5 transforming gene. J Virol 1988;62:3608-3613.
14. Szymanski P, Stenlund A: Regulation of early gene expression from the bovine papillomavirus genome in transiently transfected Cl27 cells. J Virol 1991;65:5710-5720.
15. Barksdale SK, Baker CC: Diffcrcntiation-spe-cific expression from the bovine papillomavirus type 1 P2443 and late promoters. J Virol 1993:67:5605-5616.
16. Spalholz BA: Importance of the bovine papillomavirus P2441 promoter in the regulation of E2 and E5 expression. J Virol 1993:67:6278-6284.
17. Baker CC: Sequence analysis of papillomavirus genomes; in Salzman NP, Howley PM (eds): The Papillomaviruses. New York. Plenum Press, 1987, pp 321-385.
18. Doorbar J. Parton A, Hartley K, Banks L, Crook T, Stanley M, Crawford L: Detection of novel splicing patterns in a HPV containing keratinocyte cell line. Virology 1990; 178:254-262.
19. Chen EY, Sccburg PH: Supercoil sequencing: A fast and simple method for sequencing plasmid DNA. DNA 1985;4:165-170.
20. ManiatisT, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual, ed 2. New York, Cold Spring Harbor Laboratory Press. 1989.
21. Gorman CM. Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982:2:1044-1051.
22. Kozak M: At least 6 nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987; 196:947-950.
23. Kozak M: An analysis of vertebrate mRNA sequences: Intimation of translational control. Cell 1991;115:887-903.
24. Kozak M: Point mutation defines a sequence flanking the AUG initiator codon that modulates translation by eucaryotic ribosomes. Cell 1986;44:283-292.
25. Sherman I, Alloul L: Human papillomavirus type 16 expresses a variety of alternatively spliced messenger RNAs putatively encoding the E2 protein. Virology 1992;191:953-959.
26. Rohlfs M, Winkenbach S, Meyer S, Rupp T, Dürst M: Viral transcription in human kcrati-nocyte cell lines immortalized by human papillomavirus type 16. Virology 1991:183:331-342.
27. Böhm S, Wilczynski SP, Phister H, Iftner T: The predominant mRNA class in HPV infected genital neoplasias does not encode the E6 or the E7 protein. Int J Cancer 1993:55: 791-798.
28. Sherman I. Alloul N, Golan I. Dürst M. Baram A: Expression and splicing patterns of human papillomavirus type-16 mRNAs in prc-can-cerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV-16. and in cell lines established from cervical cancers. Int J Cancer 1992;50:356-364.
29. Ushikai M, Lace MJ. Yamakawa Y, Kono M, Anson J, Ishiji T, Parkkinen S, Wicker N, Valentine M-E, Davidson I, Turek LP. Haugen TH: Trans-activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: Cooperation with activation domains of cellular transcription factors. J Virol 1994;68: 6655-6666.
30. Haugen TH. Cripc TP. Ginder GD. Karin M, Turek LP: Transactivation of an upstream early gene promoter of bovine papillomavirus-1 by a product of the viral E2 gene. EMBO J 1987;6:145-152.
31. Kozak M: Bifunctional messenger RNAs in eu-caryotes. Cell 1986;47:481-483.
32. Hershey JW: Translational control in mammalian cells. Ann Rev Biochem 1991,60:717-755.
33. Gcballe AP, Morris DR: Initiation codons within 5'-leaders of mRNAs as regulators of translation. TIBS 1994; 19:159-164.
34. Peabody DS. Berg P: Termination-reinitiation occurs in the translation of mammalian cell mRNAs. Mol Cell Biol 1986;6:2695-2703.
35. Crum CP, Nuovo G, Friedman D, Silverstein SJ: Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers. J Virol I988;62: 84-90.
36. Stolcr MH, Rhodes CR, Whitbeck A, Wolinsky SM. Chow LT, Broker TR: Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992;23:117-128.
37. Bernard BA, Bailly C, Lenoir MC, Darmon M. Thierry F, Yaniv M: The human papillomavirus type 18 E2 gene product is a repressor of the HPV-18 regulatory region in human keratinocytes. J Virol 1989;63:4317-4324.
38. Chin MT, Broker TR. Chow LT: Identification of a novel constitutive enhancer element and an associated binding protein: Implications for human papillomavirus type 11 enhancer regulation. J Virol 1989;63:2967-2976.
39. Burnett S, Järeborg N. DiMaio D: Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fìbropapillomavirus tissue. Proc Natl Acad Sci USA 1992:89:5665-5669.